Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.17.3.2 (
xanthine oxidase
)
8,383
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cigarette smoke (CS) exposure is unquestionably the most frequent cause of emphysema in the United States. Accelerated pulmonary endothelial cell (EC) apoptosis is an early determinant of lung destruction in emphysema. One of the pathogenic causes of emphysema is an alveolar oxidant and antioxidant imbalance. The enzyme
xanthine oxidoreductase
(
XOR
) has been shown to be a source of reactive oxygen species (ROS) in a multitude of diseases (S. Sakao et al., FASEB J.21, 3640-3652; 2007). The contribution of
XOR
to CS-induced apoptosis is not well defined. Here we demonstrate that C57/bl6 mice exposed to CS have increased pulmonary
XOR
activity and protein levels compared to filtered-air-exposed controls. In addition, we demonstrate that primary pulmonary human lung microvascular endothelial cells exposed to cigarette smoke extract undergo increased rates of caspase-dependent apoptosis that are reliant on
XOR
activity, ROS production, and p53 function/expression. We also demonstrate that exogenous
XOR
is sufficient to increase p53 expression and induce apoptosis, suggesting that
XOR
is an upstream mediator of p53 in CS-induced EC apoptosis. Furthermore, we show that
XOR
activation results in DNA double-strand breaks that activate the enzyme
ataxia telangiectasia mutated
, which phosphorylates histone H2AX and upregulates p53. In conclusion, CS increases
XOR
expression, and the enzyme is both sufficient and necessary for p53 induction and CS-induced EC apoptosis.
...
PMID:Xanthine oxidoreductase is a critical mediator of cigarette smoke-induced endothelial cell DNA damage and apoptosis. 2338 26